UK markets open in 2 hours 42 minutes
NIKKEI 225
37,701.52 -758.56 (-1.97%) HANG SENG
17,295.93 +94.66 (+0.55%) CRUDE OIL
82.91 +0.10 (+0.12%) GOLD FUTURES
2,326.00 -12.40 (-0.53%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,435.07 -2,071.71 (-3.87%)
AbbVie Inc. (4AB.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 12:27PM CEST
| Previous close | 156.88 |
| Open | 158.12 |
| Bid | 156.70 x 60000 |
| Ask | 157.18 x 60000 |
| Day's range | 158.12 - 159.44 |
| 52-week range | 119.00 - 168.80 |
| Volume | |
| Avg. volume | 230 |
| Market cap | 286.377B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 62.28 |
| EPS (TTM) | 2.56 |
| Earnings date | 26 Apr 2024 |
| Forward dividend & yield | 5.84 (3.72%) |
| Ex-dividend date | 12 Apr 2024 |
| 1y target est | 127.01 |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.